Description
Mitochondrial-Derived Peptide (MDP) Research Compound
MOTS-C (10mg) will be supplied in Australia by Aussie Peptides with fast domestic shipping to all states and territories.
MOTS-C is an endogenous mitochondrial-derived peptide (MDP) encoded in the mitochondrial genome — unusual among mammalian peptides, which are typically nuclear-encoded. First characterised in 2015 by researchers at the University of Southern California, MOTS-C has become a central focus of metabolic and longevity research.
Plasma MOTS-C levels decline with age and correlate with insulin resistance, reduced exercise capacity, and metabolic dysfunction in human observational studies. Mechanistically, MOTS-C translocates from mitochondria to nucleus under metabolic stress and activates AMPK — the master cellular energy regulator also activated by exercise and caloric restriction.
Key Research Areas
- Insulin Sensitivity — Studied for improved glucose uptake and insulin signalling in type 2 diabetes and metabolic syndrome models
- Exercise Adaptation — Studied for endurance and training response in preclinical models
- Metabolic Ageing — Plasma MOTS-C correlates with biological age markers; studied in longevity research
- AMPK Activation — Studied for cellular energy regulation via AMPK-mediated pathways
- Obesity Models — Studied in high-fat diet models for reversal of insulin resistance and improved fat metabolism
Supplied as lyophilized powder at ≥99% purity, verified by HPLC and mass spectrometry. 10mg per vial. Fast domestic shipping across Australia, with batch-specific CoA information available in our CoA Library.
⚠ For in-vitro research and laboratory use only. Not for human consumption.
⚠ For in-vitro research and laboratory use only. Not intended for human or veterinary use. By purchasing, you confirm you are a qualified researcher and will use this compound in accordance with all applicable laws and regulations.
Reviews
There are no reviews yet.